These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 14287991

  • 1. CHEMICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    WIEGAND RG, CHUN AH, SCHERFLING E, LOPEZ F, HERTING RL.
    Antimicrob Agents Chemother (Bethesda); 1964; 10():549-53. PubMed ID: 14287991
    [No Abstract] [Full Text] [Related]

  • 2. [ON THE PHARMACOKINETICS OF A LONG-ACTING SULFONAMIDE (4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE) IN NORMAL PERSONS].
    PORTWICH F, BUETTNER H.
    Klin Wochenschr; 1964 Aug 01; 42():740-4. PubMed ID: 14296354
    [No Abstract] [Full Text] [Related]

  • 3. CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    HERTING RL, LOPEZ F, SCHERFLING E, SYLVESTER JC, WIEGAND R.
    Antimicrob Agents Chemother (Bethesda); 1964 Aug 01; 10():554-61. PubMed ID: 14287992
    [No Abstract] [Full Text] [Related]

  • 4. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U, BEHNISCH R.
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov 01; 295/67():811-6. PubMed ID: 14001457
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy of 4-sulfanilamido-6-methoxypyrimidine in standardized infections in mice.
    REDIN GS, McCOY ME.
    Chemotherapia (Basel); 1962 Nov 01; 4():386-97. PubMed ID: 14490938
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on 3,4-dimethyl-5-sulfanilamido-isoxazole (Nu-445) in humans.
    SARNOFF SJ.
    Proc Soc Exp Biol Med; 1948 May 01; 68(1):23-6. PubMed ID: 18863664
    [No Abstract] [Full Text] [Related]

  • 11. Toxicologic and metabolic studies on 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    RANDALL LO, BAGDON RE, ENGELBERG R.
    Toxicol Appl Pharmacol; 1959 Jan 01; 1(1):28-37. PubMed ID: 13625313
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 2-Sulfanilamido-3-methoxypyrazine: a new long-action sulfonamide.
    CESANA A, VENTURA R.
    Panminerva Med; 1962 Apr 01; 4():184-7. PubMed ID: 13877775
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies on the relation of pharmacology and chemotherapeutic effect of some sulfanilamide-derivatives.
    VERHAGEN H.
    Acta Med Scand; 1948 Jun 10; 130(5):436-54. PubMed ID: 18881099
    [No Abstract] [Full Text] [Related]

  • 19. Metabolism and binding of N-(2-methyl-6-methoxy-4-pyrimidinyl) sulfanilamide (sulfamethomidine) in man.
    DICARLO FJ, MALAMENT SG, HAYNES LJ, PHILLIPS GE.
    Toxicol Appl Pharmacol; 1963 Jan 10; 5():61-70. PubMed ID: 14027680
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.